Fetal–Maternal Microchimerism Enhances the Survival Effect of Interleukin-2-Activated Haploidentical Peripheral Blood Stem Cell Treatment in Patients with Advanced Solid Cancer-Reference-Cited by-同舟云学术

Fetal–Maternal Microchimerism Enhances the Survival Effect of Interleukin-2-Activated Haploidentical Peripheral Blood Stem Cell Treatment in Patients with Advanced Solid Cancer

Published:2010-12 Issue:6 Volume:25 Page:741-746
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Han Ying¹,Yu Jinpu²,Cao Shui¹,Li Hui²,Ren Baozhu¹,An Xiumei²,Zhang Naining²,Qi Jing²,Ren Xiubao¹

Affiliation:

1. Cancer Biotherapy Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.

2. Key Laboratory of Cancer Prevention and Therapy, Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2010.0770

Reference25 articles.

1. Aims of conditioning

2. Transplantation of haploidentically mismatched stem cells for the treatment of malignant diseases

3. The history and future prospective of haplo-identical stem cell transplantation

4. T-cell depletion of HLA-identical transplants in leukemia

5. Cellular immunotherapy and cancer

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic effect of haploidentical peripheral blood stem cell treatment on relapsed/refractory ovarian cancer;Bulletin du Cancer;2023-03

2. Incognito: Are Microchimeric Fetal Stem Cells that Cross Placental Barrier Real Emissaries of Peace?;Stem Cell Reviews and Reports;2018-06-15

3. Do We Need Full Donor Chimerism? How Alloreactive Cell Therapies without Substantial Engraftment Might Treat Hematologic Cancers;Current Drug Targets;2017-01-24

4. Frequency of fetal-maternal microchimerism: an analysis of the HLA-DRB1 gene in cord blood and maternal sample pairs;The Journal of Maternal-Fetal & Neonatal Medicine;2016-12-07

5. Harnessing the power of alloreactivity without triggering graft-versus-host disease: how non-engrafting alloreactive cellular therapy might change the landscape of acute myeloid leukemia treatment;Blood Reviews;2014-11